{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Yang J"],"pubmed_abstract":["Purpose
Pre-diabetes significantly increases the risk of type 2 diabetes and cardiovascular disease. Magnesium deficiency is common and may contribute to dysglycemia. However, evidence for the efficacy of magnesium supplementation in pre-diabetes, especially in older adults with hypomagnesemia, remains limited and inconclusive. This exploratory trial aimed to evaluate the effects of oral magnesium supplementation on glycemic parameters and conducted exploratory metabolomic profiling in this population.Methods
In this 4-month, randomized, double-blind, placebo-controlled trial, 71 community-dwelling older adults (mean age 68.7 ± 6.0 years) with pre-diabetes (fasting plasma glucose ≥5.6 mmol/L and/or HbA1c 5.7%-6.5%) and hypomagnesemia (plasma magnesium ≤ 0.80 mmol/L) were en"],"journal":["Frontiers in nutrition"],"pagination":["1765308"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12932175"],"repository":["biostudies-literature"],"pubmed_title":["Oral magnesium supplementation improves glycemic control in older Chinese adults with pre-diabetes and hypomagnesemia: a randomized controlled trial."],"pmcid":["PMC12932175"],"pubmed_authors":["Li G","Ding G","Yang J","Li Y","Yang L","Zhang H","Guo C","Wu W","Ding J","Wang J","Wu Y","Pan M"],"additional_accession":[]},"is_claimable":false,"name":"Oral magnesium supplementation improves glycemic control in older Chinese adults with pre-diabetes and hypomagnesemia: a randomized controlled trial.","description":"Purpose
Pre-diabetes significantly increases the risk of type 2 diabetes and cardiovascular disease. Magnesium deficiency is common and may contribute to dysglycemia. However, evidence for the efficacy of magnesium supplementation in pre-diabetes, especially in older adults with hypomagnesemia, remains limited and inconclusive. This exploratory trial aimed to evaluate the effects of oral magnesium supplementation on glycemic parameters and conducted exploratory metabolomic profiling in this population.Methods
In this 4-month, randomized, double-blind, placebo-controlled trial, 71 community-dwelling older adults (mean age 68.7 ± 6.0 years) with pre-diabetes (fasting plasma glucose ≥5.6 mmol/L and/or HbA1c 5.7%-6.5%) and hypomagnesemia (plasma magnesium ≤ 0.80 mmol/L) were en","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026","modification":"2026-07-16T22:11:28.881Z","creation":"2026-07-14T03:03:45.736Z"},"accession":"S-EPMC12932175","cross_references":{"pubmed":["41756632"],"doi":["10.3389/fnut.2026.1765308"]}}